MedPath

XOLAIR

XOLAIR

Approved
DIN Number

02545152

Drug Class

Human

Market Date

N/A

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02545152
AIG Number0150422001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
R03DX05 OMALIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:28.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

OMALIZUMABActive
Strength: 300 MG / 2 ML
Monograph: OMALIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.